biosimilars

The definitive source for news and information on Biosimilars. Stay up-to-date and informed.

[biosimilars @biosims]

Vicebio closes $100m financing round to advance multivalent vaccine technology

[biosimilars @biosims]

UCB and Biogen announce positive Phase 3 results for dapirolizumab pegol in systemic lupus erythematosus

[biosimilars @biosims]

AI study shows GLP-1s could help prevent heart disease in millions

[biosimilars @biosims]

Pricing and logistics: The challenges of getting mpox vaccines to the front line

[biosimilars @biosims]

Novartis’ Kisqali receives FDA approval to reduce the risk of breast cancer recurrence

[biosimilars @biosims]

Cellevate bags €3.2 million to smash viral vector manufacturing bottleneck

[biosimilars @biosims]

Aurora Biosynthetics launches to boost RNA therapeutics manufacturing in Asia-Pacific

[biosimilars @biosims]

Eli Lilly expands manufacturing facilities in Ireland with $1.8bn investment

[biosimilars @biosims]

Women in science - Alison O'Neill at YPrime on thinking out loud and collaborating

[biosimilars @biosims]

MinervaX and Wacker Biotech partner to scale up GBS vaccine production

[biosimilars @biosims]

Eli Lilly's eczema drug receives FDA approval one year after its initial rejection

[biosimilars @biosims]

FDA designations boost AI-driven cell therapy approach for Duchenne muscular dystrophy

[biosimilars @biosims]

Vaxess' Rachel Sha - 'own the seat at the table that you have and have confidence'

[biosimilars @biosims]

Eli Lilly reports positive phase 3 results for a weekly insulin formulation

[biosimilars @biosims]

FDA lifts partial clinical hold on phase 3 low blood sugar treatment

[biosimilars @biosims]

How modern trial designs propel cancer therapies to the market - interview

[biosimilars @biosims]

Women in Science - Emmanuelle Cameau on growing stronger from challenges

[biosimilars @biosims]

Neuromuscular diseases in crosshairs in Forge Biologics gene therapy collaboration

[biosimilars @biosims]

Therapy for aggressive brain cancer receives FDA clearance to start phase 1

[biosimilars @biosims]

Women in Science - Beate Mueller on the privilege of bringing solutions closer to patients